Workflow
Healthcare Services
icon
Search documents
AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026
Globenewswire· 2026-02-26 15:00
Core Insights - Nearly three-quarters of healthcare executives believe their organizations will be as strong or stronger in 2026, while over half expect the overall healthcare industry to face a worse year ahead, indicating a widening confidence gap [1][7] - The demand for AI-savvy leaders is surging, with 63% of leaders prioritizing the development of a clear AI strategy, 48% focusing on clinician and staff engagement for adoption, and 41% emphasizing investment in data infrastructure [3][7] - Succession planning remains underdeveloped, with fewer than half of organizations maintaining formal succession plans for any leadership level [7] Industry Trends - The 2026 Healthcare Leadership Trends survey, conducted by B.E. Smith, gathered insights from 703 healthcare executives across various leadership levels and organizational types [2][5] - Leaders are navigating financial pressures, workforce realities, and rising expectations for innovation, with a focus on adaptable leadership that can leverage AI and technology for operational improvements [3][6] - Retention risk shows signs of cooling, but 35% of leaders considering leaving would like to do so within one year, indicating ongoing mobility concerns [7] Leadership Challenges - Attracting quality leadership candidates remains extremely or very challenging for 40% of respondents, highlighting difficulties in leadership recruiting [7] - Clinician engagement continues to lag, with leadership teams perceived as more engaged compared to physicians and nursing staff, reflecting ongoing workforce experience challenges [7] - Career advancement is a friction point, as only 21% of respondents feel they are on a promotion track, while 26% believe they must leave their employer to advance [7]
Privia Health (PRVA) - 2025 Q4 - Earnings Call Transcript
2026-02-26 14:02
Privia Health Group (NasdaqGS:PRVA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAndrew Mok - Director of Equity ResearchDavid Larsen - Managing DirectorDavid Mountcastle - EVP and CFOJailendra Singh - Managing DirectorJenny Shen - Equity Research AssociateLisa Gill - Managing DirectorMatthew Shea - VP of Equity ResearchParth Mehrotra - CEORobert Borchert - SVP of Investor and Corporate CommunicationsRyan Halstead - Managing Director of Equity ResearchConference Call ParticipantsA ...
Privia Health (PRVA) - 2025 Q4 - Earnings Call Transcript
2026-02-26 14:02
Privia Health Group (NasdaqGS:PRVA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAndrew Mok - Director of Equity ResearchDavid Larsen - Managing DirectorDavid Mountcastle - EVP and CFOJailendra Singh - Managing DirectorJenny Shen - Equity Research AssociateLisa Gill - Managing DirectorMatthew Shea - VP of Equity ResearchParth Mehrotra - CEORobert Borchert - SVP of Investor and Corporate CommunicationsRyan Halstead - Managing Director of Equity ResearchConference Call ParticipantsA ...
Privia Health (PRVA) - 2025 Q4 - Earnings Call Transcript
2026-02-26 14:00
Privia Health Group (NasdaqGS:PRVA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Speaker15Good morning, ladies and gentlemen, thank you for standing by. My name is Kelvin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Privia Health Fourth Quarter Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. If you would like to ask a question during th ...
Agilon Health, Inc. Q4 2025 Earnings Call Summary
Yahoo Finance· 2026-02-26 13:30
Performance in 2025 was impacted by elevated medical cost trends, specifically a step-up in inpatient volume and several discrete multimillion-dollar claims in the third quarter. Management is executing a strategic pivot that prioritizes economic sustainability over membership growth, leading to the intentional exit of unprofitable payer contracts. The company is migrating certain markets to care coordination fee models to reduce downside risk while maintaining a long-term path to full-risk arrangemen ...
Nutex Health: The $387 Million Receivables Problem And The Legislative Silver Bullet
Seeking Alpha· 2026-02-26 13:19
This is my first cover of Nutex Health ( NUTX ). In this article, I will describe their business, and the recent developments. I will talk about how the issue of insurers not paying providersI first entered investing in 2016 as an individual value investor. In 2022, I established the investment firm Libra Capital. I mostly write articles as part of my deep research into a company before I make an investment, whether long or short. For me, a ''hold'' article means neutral; don't touch the stock and exit a po ...
Agilon Health Q4 Earnings Call Highlights
Yahoo Finance· 2026-02-26 11:54
Williams also addressed CMS’s Medicare Advantage (MA) Advance Notice for 2027, saying the proposal “does not sufficiently reflect” rising costs and utilization from chronic disease and an aging Medicare population. He said the company expects the impact of the risk model revision and normalization described in the Advance Notice to be “generally in line with the national average,” and argued that agilon’s burden of illness and clinical pathway programs can help mitigate risk model impacts, as they did durin ...
Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
Globenewswire· 2026-02-26 11:30
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 19, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and ca ...
Universal Health Services (UHS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2026-02-26 02:30
Core Insights - Universal Health Services (UHS) reported revenue of $4.49 billion for the quarter ended December 2025, reflecting a 9.1% increase year-over-year and a slight revenue surprise of +0.05% over the Zacks Consensus Estimate of $4.48 billion [1] - Earnings per share (EPS) for the quarter was $5.88, up from $4.92 in the same quarter last year, although it fell short of the consensus estimate of $5.92, resulting in an EPS surprise of -0.63% [1] Financial Performance - Net Revenues from Acute Care Hospital Services reached $2.55 billion, exceeding the average estimate of $2.51 billion by four analysts, with a year-over-year increase of +9.8% [4] - Net Revenues from Behavioral Health Services were reported at $1.94 billion, slightly below the estimated $1.97 billion, marking an +8.1% change compared to the previous year [4] - Net Revenues from Other services totaled $2.95 million, under the average estimate of $3.28 million, with a year-over-year increase of +11.8% [4] - Operating Income for Behavioral Health Care Services was $382.09 million, below the average estimate of $436.21 million [4] - Operating Income for Acute Care Hospital Services was $251.68 million, slightly above the average estimate of $245.66 million [4] Stock Performance - Shares of Universal Health Services have returned +13.5% over the past month, contrasting with a -0.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]
agilon health (AGL) Q4 2025 Earnings Transcript
Yahoo Finance· 2026-02-26 00:00
In addition, given the focus of our model is the assessment of conditions at the point of care with diagnoses tied to documentation from a visit, we believe we have minimal exposure to unlinked or audio-only coding. We believe our ability to differentiate on the management of medical cost and quality outcomes should continue to position us well with health plans and physicians, with the expectation that the rate and cost spread will ultimately normalize over time. Throughout the year, we advanced several ke ...